-transparent.png){kind=logo}
BACKGROUND Estrogen replacement therapy (ERT) may delay dementia-related cognitive decline in post-menopausal women, but few studies have longitudinally examined this relationship and none has controlled for baseline functioning or concurrent medication. METHODS We report the results of a 1-year retrospective longitudinal study examining cognitive functioning in female estrogen and nonestrogen users (n = 3128) who presented to the state of California memory disorder clinics in a naturalistic multisite study of senile dementia, Alzheimer's type (SDAT), and other cognitive impairments. RESULTS At baseline, estrogen users had significantly lower rates of SDAT diagnoses (possible and probable) than nonestrogen users, and significantly higher rates of the lesser diagnoses of "cognitive impairment" and "no dementia." ERT was significantly associated with higher cognitive functioning at baseline and at 1 year follow-up (n = 358). Nonestrogen users deteriorated significantly from baseline to follow-up; estrogen users did not. Results were similar in groups matched on baseline Blessed-Roth Dementia Rating Scale (BRDRS) ratings (n = 32) and in a variety of subpopulations. CONCLUSIONS These findings are consistent with estrogen acting as a protective factor against cognitive deterioration in post-menopausal women with SDAT and other cognitive impairments, and may suggest an increased effect in earlier stages of cognitive impairment.
M M Costa, and
V I Reus, and
O M Wolkowitz, and
F Manfredi, and
M Lieberman
May 1999,
Journal of the American Geriatrics Society,
M M Costa, and
V I Reus, and
O M Wolkowitz, and
F Manfredi, and
M Lieberman
June 2007,
Human reproduction (Oxford, England),
M M Costa, and
V I Reus, and
O M Wolkowitz, and
F Manfredi, and
M Lieberman
January 1988,
Psychoneuroendocrinology,
M M Costa, and
V I Reus, and
O M Wolkowitz, and
F Manfredi, and
M Lieberman
July 1968,
Rivista di ostetricia e ginecologia,
M M Costa, and
V I Reus, and
O M Wolkowitz, and
F Manfredi, and
M Lieberman
October 1985,
The Nurse practitioner,
M M Costa, and
V I Reus, and
O M Wolkowitz, and
F Manfredi, and
M Lieberman
January 1992,
Adverse drug reactions and toxicological reviews,
M M Costa, and
V I Reus, and
O M Wolkowitz, and
F Manfredi, and
M Lieberman
March 1999,
Maturitas,
M M Costa, and
V I Reus, and
O M Wolkowitz, and
F Manfredi, and
M Lieberman
June 1976,
The New England journal of medicine,
M M Costa, and
V I Reus, and
O M Wolkowitz, and
F Manfredi, and
M Lieberman
January 1995,
Cancer,
M M Costa, and
V I Reus, and
O M Wolkowitz, and
F Manfredi, and
M Lieberman
September 2007,
QJM : monthly journal of the Association of Physicians,
